Print Friendly, PDF & Email

3) Effective drug pricing in the country is a problem still waiting for a solution. Examine in context of the parliamentary panel report ?(250 words)

Topic– Issues relating to development and management of Social Sector/Services relating to Health

3) Effective drug pricing in the country is a problem still waiting for a solution. Examine in context of the parliamentary panel report ?(250 words)

Downtoearth

 

Why this question

The article analyzes the parliamentary committee report on how the centre has failed to not just reign in escalating drug prices but has also not been able to curb the business of substandard drugs. High OoPE is a huge issue when it comes to health management in the country and the issue is closely related to that.

Key demand of the question

The question expects us to discuss the details of the parliamentary committee report, discuss the reasons why the parliamentary committee report has come to the conclusions that it has and the impact of the report. Thereafter, we need to give suggestions regarding what can be done to improve the situation.

Directive word

Examine – When you are asked to examine, you have to probe deeper into the topic,  get into details, and find out the causes or implications if any .

Structure of the answer

Introduction – Highlight that OoPE is a major health management related issue in the country in which high drug cost has a huge role. Also, highlight the problem of spurious drugs.

Body

  • Discuss details of the report
    • The Centre has failed to not just reign in escalating drug prices but has also not been able to curb the business of substandard drugs, according to a Parliamentary standing committee report
    • drugs account for more than 70 per cent of one’s medical expenses.
    • anyone hardly ever invests on drug innovation in India
    • panel also highlighted that difference between prices of drugs sold at Jan Aushadhi Kendras (JAKs) and that of branded medicines is too high due to promotional cost. So it asked the government to ensure drug prices are not more than a certain ceiling fixed by National Pharmaceutical Pricing Authority. But, it did not define the ceiling.
    • there are too few JAKs in the country etc
  • Discuss the reasons for the issues as highlighted above and evaluate the findings of the committee
    • The recommendation of the committee to bring more number of drug formulations under the NLEM will not sit well with the drug manufacturers who feel that such ceiling adversely impact innovations
    • Moreover the focus should be on ensuring adherence etc
  • Discuss the impact of the recommendations of the committee

Conclusion – Give your view and suggest way forward.

CategoriesINSIGHTS